Skip to main content
Back to CDP Venture Capital

CDP Venture Capital's Life Science Portfolio

Browse 7 Life Science companies funded by CDP Venture Capital. See funding amounts, founder contacts, and investment details.

Life Science Companies
7
Total Funding in Life Science
$237.3M

Life Science Portfolio Companies (7)

Export
BiotechnologyLife ScienceTherapeutics

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Milan, Italy
September 2024
$52.2M
Series B

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceNeurosciencePharmaceutical

IAMA Therapeutics is a pharmaceutical business that develops novel therapeutics for unmet medical needs in the brain.

Genoa, Italy
April 2025
$17.1M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Computer VisionEnterprise SoftwareFinancial ServicesIndustrialLife ScienceManufacturingOil and GasPredictive AnalyticsSoftware

Alomana harnesses artificial intelligence and data analytics to drive insights and innovation across various industries.

Milan, Italy
March 2026
$4.6M
Seed

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife Science

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Torino, Italy
March 2022
$20.4M
Series B

Founder Contacts

41,000+ verified contacts

Alternative ProteinBiotechnologyBrewingFood and BeverageHardwareLife Science

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Rome, Italy
September 2025
$996K
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceNanotechnology

GI develops super-resolution optical microscopes, empowering researchers to explore the microscopic world with unprecedented detail.

Genova, Italy
February 2025
$1.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Milano, Italy
November 2025
$141.0M
Series B

Founder Contacts

41,000+ verified contacts

Explore CDP Venture Capital's Full Portfolio

View all companies funded by CDP Venture Capital across every industry and funding stage.

View Full CDP Venture Capital Portfolio